Treatment of glomus jugulare tumors with radiosurgery has grown in acceptance since the first reported treatment in 1995, but only a few centers have reported their experiences with limited follow up time. We report our experience with stereotactic radiosurgery in nine patients with ten glomus tumors. All patients were treated either with frame based LINAC or Cyberknife with doses ranging from 1600 cGy to 2500 cGy. Three patients received no previous therapy and one patient received additional external beam radiation for concomitant treatment of carotid body tumors. Patients were then followed for post treatment side effects in addition to change in tumor size by MRI evaluation. The median clinical follow-up time was 26 months (mean 54 months), median radiographic follow-up was 21.5 months (mean 46 months), with a range from 3 to 126 months. The results from our center demonstrated nine of ten tumors to be stable in size by MRI exam, and one tumor which regressed in size. Nine patients had stable neurological symptoms, and one patient experienced transient ipsilateral tongue weakness and hearing loss, both of which subsequently resolved.
Introduction
Glomus Jugulare tumors, otherwise known as paragangliomas, comprise 0.6% of all tumors and are slow growing vascular tumors that arise from the glomus bodies located along the carotid sheath (1). Patients usually present with cranial nerve deficits, and these tumors can occasionally cause thrombus of the venous structures. Surgical resection carries a high complication rate, which includes stroke (8-20%) , cranial nerve injury (33-44%), and an overall mortality rate of 5-13% (1). Subtotal resection is commonly encountered, and patients require further treatment in the forms of additional surgery, embolization, or radiation.
Treatment of glomus jugulare tumors with radiosurgery has been reported by few centers but overall, the series sizes have been small with only short term followup. We report our experience in treating glomus jugulare tumors with stereotactic radiosurgery, examining both efficacy and side effects of treatment.
Materials and Methods
The Stanford University Hospital radiosurgery database was screened for patients with glomus jugulare tumors treated with stereotactic radiosurgery from 1991 to 2001. Patient records were reviewed for age, sex, laterality of tumor, dose, isocenters, pre-treatment and post treatment symptoms, size of tumor by MRI before and after therapy, and length of follow-up based on radiographs and symptoms (Table 1) .
Patients ranged in age from 21 to 73 with a mean of 44 years. There were a total of nine patients: 5 females and four males. Five patients had prior open surgeries for their tumors, with two patients having undergone multiple attempts at resection. Four of the nine patients were treated exclusively with radiosurgery because of other medical conditions that excluded surgery as a viable option. Tumor sizes ranged from 1.2 cm to 3.6 cm at the largest measurable diameter with an average of 2.4 cm (Table 2) . Of the 5 patients presenting with recurring tumors (all previously resected with histology consistent with glomus tumors), one had a tumor that extended up to the cavernous sinus, while the remainder had local recurrences. Presenting symptoms involved cranial nerves IX (3/9 patients), X (2/9 patients), XI (2/9 patients), and XII (2/9 patients).
Six tumors were treated with a frame based LINAC system, and the remaining four were treated with the Cyberknife. Prescribed doses (typically to the 80% isodose line) to the periphery of the tumor ranged from 1600 cGy to 2500 cGy with one to three isocenter treatments except for those patients treated by the Cyberknife who received non-isocentric based treatments. Clinical length to follow-up was based on symptoms documented by phone interview and by their most recent MRI. Follow-up of patients ranged from 3 months to 126 months on radiographs (median 21.5 months, mean 46 months), and 13 months to 157 months with clinical follow-up (median 26 months, mean 54 months). Stanford IRB approval and patient consent were obtained for performing the research study and reviewing patient medical records.
Results
Post treatment, one patient experienced transient worsening of preprocedural cranial nerve deficits as evidenced by ipsilateral tongue atrophy and hearing loss, but both of these symptoms subsequently resolved. One patient complained of a dry mouth and loss of teeth, but she had also received concomitant external beam radiation for a carotid body tumor at the same time and these symptoms were felt to be unrelated to the radiosurgical treatment. The remaining seven patients experienced no side effects. Nine tumors were stable at the time of follow-up which ranged from 3 months to 126 months (median 21.5 months) per radiograph ( Figure 1 ). One patient, treated with stereotactic radiosurgery alone, had a regression of her tumor size. Her pretreatment tumor was one of the largest radiographically at 3.8 cm maximal diameter (42.3 cc volume), and at 15 months, it had decreased to 3.4 cm maximal diameter.
Discussion
Glomus Jugulare tumors are generally regarded as indolent well-vascularized tumors. They have been known to secrete (2). Surgical treatment of glomus jugulare tumors carries a significant morbidity, primarily from damage to the lower cranial nerves IX-XII (2). As a result of this morbidity, radiotherapy and radiosurgery has emerged as alternative treatment options for selected patients with glomus tumors.
External beam radiation has been shown to decrease and or ameloriate clinical symptoms in as much as 71% of the cases with 61% of the tumors showing a reduction of tumor size (3). The field size used to deliver conventional external beam radiotherapy in the upper neck and skull base has, in rare cases, resulted in secondary complications of radionecrosis of bone and possible induction of secondary malignancies (2). Furthermore, conventional external beam radiotherapy of the upper neck also results in the more common side effect of xerostomia. The recent use of intensity modulated radiation therapy (IMRT) has reduced the extent of normal tissue exposed to radiation, reducing potential side effects. However, IMRT still does not deliver as high a degree of target conformality as stereotactic radiosurgery.
Rationale for Radiosurgery
Stereotactic radiosurgery should be particularly beneficial for glomus jugulare tumors, as these tumors are well defined and non infiltrating. Furthermore, these lesions usually present at a reasonably small size because of their proximity to cranial nerves, whose dysfunction often heralds the presence of tumor. It is precisely such well demarcated small targets for which radiosurgery is well suited. While conventional radiation therapy of glomus tumors includes treatment of a significant amount of normal tissue, the steep dose gradient achievable with radiosurgery minimizes irradiation of these areas. As a result, it is possible to deliver a larger, and presumably more efficacious doses per treatment without exceeding the radiation tolerance of normal tissues. In addition, a therapeutic gain may be achieved by treating slowly proliferating tumors, such as glomus jugulare tumors, with larger doses per treatment, a treatment possible with radiosurgical techniques.
Despite the theoretical benefits of using radiosurgery to treat glomus jugulare tumors, there are obvious drawbacks as well. Radiosurgery by definition requires precise target delineation. However, small treatment delivery errors (typically on the order of 1 to 2 mm) within any radiosurgical device can result in underdosing of portions of the edge of a tumor, resulting in a marginal miss. Furthermore, while imaging techniques are much improved, the anatomy of the neck with respect to cranial nerves is especially complex. Modern imaging cannot reliably separate tumor from adjacent cranial nerve when targeting radiosurgery treatment, whereas such concerns are of less importance with external beam radiotherapy. Furthermore, despite the focused nature of radiosurgery, the close spatial relationship between glomus tumors and cranial nerves inevitably results in some irradiation of these cranial nerves, and the possibility of damaging normal neurologic tissue remains an ongoing risk. Permanent cranial nerve deficits are rare, but possible side effects of stereotactic radiosurgery.
In 1995, the first published series on radiosurgery was introduced as a viable alternative to standard surgical resection (4). Since then, several additional studies have been reported in the literature (2, (5) (6) (7) (8) (9) (10) In all series other than Feigenberg, et al., all tumors have been documented as stable or decreased. In most centers, the number of patients treated were relatively small with follow up time ranging from a median or average of 20-50 months. The age groups ranged from 48 years to 68 years while our group was slightly younger, with an average age of 44.1 years. Our prescribed dose to the tumor margin varied from 1600 to 2500 cGy. We typically chose to treat to greater than 2000cGy for small to medium sized tumors, but lowered the dose for the largest volume tumors due to concerns about radiation side effects as volume increased. Lastly, complications in the multicenter and single center experiences have been minor, with most series reporting only transient dizziness or occasional hearing loss.
Our series confirms the arrest of tumor progression using either frame based LINAC radiosurgery or Cyberknife radiosurgery. In this series, all tumors were stable in size or decreased with MRI follow-up to 126 months. Compared to the existing literature, our average tumor size was larger, but despite this factor, no tumor progressed following treatment. As for complications, one patient in our series experienced transient cranial nerve symptoms, and no patient had permanent cranial nerve deficits.
Cranial Nerve Complications
Given the nature of glomus jugulare tumors, involved cranial nerves must necessarily be treated to full dose. The radiation tolerance of cranial nerves revealed in this study confirms other reports which note the radiation resistance of most motor cranial nerves (2, 7, 9) . In our series, only one patient developed worsening cranial nerve deficits, and these deficits were temporary. The other series have noted similar findings, with special sensory nerves such as cranial nerve VIII being the most sensitive to treatment if it is involved in the radiosurgery treatment field. Such complication rates after radiosurgical treatment of glomus tumors compare very favorably with the morbidity associated with microsurgical resection. As discussed above, surgical resection of these lesions is associated with a cranial nerve injury rate of 33-44%, and an overall mortality rate of 5-13% (1).
Limitations of the Present Study
There are several drawbacks to this current clinical report. Given the long natural history of glomus jugulare tumors, which is probably best discussed in terms of decades and not years, the primary weakness is the relatively short follow-up (median 26 months clinical follow-up; 21.5 months imaging follow-up). Since some glomus tumors can lay dormant for years, longer follow-up of the patients in this series is necessary before we can be certain that such tumors are completely "ablated". Although comparable to other radiosurgical series involving glomus tumors, it is not known if long term outcome will parallel the results reported here. We expect at a minimum that the results with more recently treated patients will likely be as good as earlier cases since prior cases were treated with older radiosurgical techniques, which used less sophisticated treatment planning. Nevertheless, given that glomus tumors can grow slowly, longer follow-up is necessary by our center and others to confirm the durability of the radiosurgery treatment. Despite this issue, patients with glomus tumors who are either elderly or who are poor operative candidates may consider stereotactic radiosurgery as a reasonable treatment option.
Summary
Stereotactic radiosurgery remains a viable form of treatment for glomus jugulare tumors as evidenced by a median 21.5 month radiographic follow-up. Our short term results shows that LINAC based radiosurgery is a safe and efficacious form of therapy for treatment of glomus jugulare tumors, and are comparable to the published Gamma Knife series.
